Results 221 to 230 of about 2,532,893 (407)

Effects of antibodies to Torpedo acetylcholine receptor on the acetylcholine receptor-lonic channel complex of Torpedo electroplax and rabbit intercostal muscle

open access: bronze, 1979
Mohyee E. Eldefrawi   +6 more
openalex   +1 more source

Management of Anxiety in Parkinson's Disease

open access: yesMovement Disorders Clinical Practice, EarlyView.
ABSTRACT Background Anxiety is a common, distressing, hard‐to‐diagnose and hard‐to‐treat symptom in Parkinson's disease. No formal guidelines exist to assist management. Objective We provide a pragmatic guide to detecting and managing anxiety in Parkinson's disease.
Alex J. Berry   +4 more
wiley   +1 more source

Retraction: Induction of Hypoxia-inducible Factor 1 Activity by Muscarinic Acetylcholine Receptor Signaling. [PDF]

open access: yesJ Biol Chem
Hirota K   +6 more
europepmc   +1 more source

Reaction of tetraethylammonium with the open and closed conformations of the acetylcholine receptor ionic channel complex. [PDF]

open access: bronze, 1979
Michael Adler   +4 more
openalex   +1 more source

Acetylcholine Receptors [PDF]

open access: yesBiophysical Journal, 2008
openaire   +1 more source

Basal Forebrain Volume Predicts Disease Conversion in Prodromal Synucleinopathy

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Isolated rapid eye movement sleep behavior disorder (iRBD) is a prodromal stage of Parkinson's disease (PD) and dementia with Lewy bodies (DLB). The basal forebrain (BF), a key cholinergic structure, is a site of known pathology in later stages of Lewy body disorders.
Lachlan Churchill   +5 more
wiley   +1 more source

Efficacy and Safety of IncobotulinumtoxinA for Treatment of Sialorrhea: A Multicenter, Phase 3 Study in Japan

open access: yesMovement Disorders Clinical Practice, EarlyView.
This study demonstrated significant treatment efficacy and safety of incobotulinumtoxinA injection in Japanese patients with chronic sialorrhea caused by Parkinson's disease and other neurological conditions. Suppression of salivary secretion and improvement in drooling symptoms were also observed throughout 48 weeks.
Nobutaka Hattori   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy